MedTrace Logo

Ocular Changes in Vitiligo Patients on Therapy

NCT05335746 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-04-19

No results posted yet for this study

Summary

Vitiligo patients on systemic and local therapy may have some ocular adverse effects associated with the disease and its therapy.

Conditions

  • Vitiligo
  • Chorioretinopathy
  • Chorioretinitis

Interventions

DIAGNOSTIC_TEST

Optical coherence tomography angiography (OCT-A)

Optical coherence tomography angiography scanning will be done for all subjects in the study.

Sponsors & Collaborators

  • Benha University

    lead OTHER

Principal Investigators

  • Amal A Yousif, MD · Benha University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-10
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05335746 on ClinicalTrials.gov